A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...
GLP-1 and nutrition: managing risks for at-risk patients. Dr Almandoz shares key insights on malnutrition risks in post-bariatric and older patients, plus how to tailor care for better outcomes.
GLP-1s and nutrition: quality over restriction! Dr Almandoz shares how shifting from restrictive diets to evidence-based, ...
Using ALK+ lung cancer patient-derived cell lines, researchers have performed phosphoproteomic screening and identified guanylate kinase 1 (GUK1) as a TKI sensitive metabolic molecule in ALK-driven ...
Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback